Gold in the ivory tower: Equity rewards of outlicensing

Article Abstract:

The analysis of life-science initial public offerings (IPOs) from three time periods have shown that the equity share received by universities and their academic researchers has changed over time. The financial significance of equity in university-biotech licenses are evaluated on the basis of the IPO pricing and as a function of the aggregate technology value of the group of companies going public in that period.

Forecasts and trends, Market trend/market analysis, Going public (Securities), Initial public offerings, Company public offering

---

The hermit crab solution

Article Abstract:

Public listing is becoming the most popular alternative for the initial public offering (IPO) for most of the biotech companies. Biotech is a capital-intensive industry and given the importance of public stock, they are increasingly opting for an alternative called reverse merger, which are the mergers of private companies into public shells.

Acquisitions & mergers, Mergers, acquisitions and divestments, Company acquisition/merger, Industry forecasts

---

Who took the tech out of biotech?

Article Abstract:

The impact of financial pressures on the research and innovativeness of the biotechnology company is discussed. Biotechnology investing is suited to those investors who are capable of evaluating new technologies and understanding nontraditional metrics.

Product development, Financial management, New York, Financial Systems & Controls, Finance, Company financing

Similar abstracts:

• Abstracts: Synthetic gene firms evolve toward sustainable business? The past, present, and future of biotechnology in Mexico
• Abstracts: Volume, opinion divergence, and returns: a study of post-earnings announcement drift. The role of accruals in asymmetrically timely gain and loss recognition
• Abstracts: In need of deficit defying tricks. With a little help from friends
• Abstracts: Toll-like receptor therapies compete to reduce side effects. Belated approval of first recombinant protein from animal
• Abstracts: Not for the chicken-hearted. Susan Wood. Finding the moral high ground

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.